- Home
- PINC vs ANIP Comparison
PINC vs ANIP Comparison
Compare PINC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- ANIP
- Stock Information
- Founded
- PINC 2013
- ANIP 2001
- Country
- PINC United States
- ANIP United States
- Employees
- PINC N/A
- ANIP N/A
- Industry
- PINC Other Consumer Services
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- PINC Consumer Discretionary
- ANIP Health Care
- Exchange
- PINC Nasdaq
- ANIP Nasdaq
- Market Cap
- PINC 2.3B
- ANIP 2.0B
- IPO Year
- PINC 2013
- ANIP N/A
- Fundamental
- Price
- PINC $28.20
- ANIP $83.50
- Analyst Decision
- PINC Hold
- ANIP Strong Buy
- Analyst Count
- PINC 6
- ANIP 7
- Target Price
- PINC $26.13
- ANIP $99.29
- AVG Volume (30 Days)
- PINC 868.6K
- ANIP 413.5K
- Earning Date
- PINC 11-04-2025
- ANIP 11-07-2025
- Dividend Yield
- PINC 2.98%
- ANIP N/A
- EPS Growth
- PINC N/A
- ANIP N/A
- EPS
- PINC N/A
- ANIP 1.67
- Revenue
- PINC $1,004,509,000.00
- ANIP $826,880,000.00
- Revenue This Year
- PINC N/A
- ANIP $40.23
- Revenue Next Year
- PINC $3.13
- ANIP $9.65
- P/E Ratio
- PINC N/A
- ANIP $50.17
- Revenue Growth
- PINC N/A
- ANIP 48.87
- 52 Week Low
- PINC $17.23
- ANIP $52.50
- 52 Week High
- PINC $28.79
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- PINC 62.95
- ANIP 27.85
- Support Level
- PINC $28.05
- ANIP $79.39
- Resistance Level
- PINC $28.22
- ANIP $95.45
- Average True Range (ATR)
- PINC 0.05
- ANIP 4.35
- MACD
- PINC -0.04
- ANIP -1.05
- Stochastic Oscillator
- PINC 79.17
- ANIP 23.73
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.